Genome Surveillance Overview

  • Founded
  • 2015

  • Status
  • Out of Business

  • Employees
  • 3

  • Latest Deal Type
  • Out of Business

Genome Surveillance General Information


Developer of a scaffold sequencing technology intended to meet the growing need for faster and accurate DNA sequencing. The company's technology allows medical researchers to obtain accurate genomic information for genome reconstruction and structure variation discovery, molecular marker development and agricultural research, making DNA sequencing ten times faster and more accurate with a fraction of cost compared to existing technologies.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 479 Jessie Street
  • Madison, WI 53719
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genome Surveillance Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Sep-2016 00000 Completed Out of Business
2. Accelerator/Incubator 14-Mar-2016 00000 00000 00000 Completed Startup
1. Capitalization Completed Startup
To view Genome Surveillance’s complete valuation and funding history, request access »

Genome Surveillance Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial